27 closest matches · ranked by relevance
Physiological Function in Low Oxygen Environment
Primary: Magnitude of Decrement in Exercise Time Trial Performance in Hypoxia (Low Oxygen) Compared With Normoxia (Normal Oxygen). — 22.3; 25.2; 22.2; 24.0 minutes
Mountain Sickness
Primary: Change in Environmental Symptoms Questionnaire at High Altitude — 0.132; 0.122; 0.080; 0.069 score on a scale
Acute Mountain Sickness
Primary: Number of Participants With Acute Mountain Sickness — 24; 22; 15 Count of participants
Acute Mountain Sickness
Primary: Incidence of Acute Mountain Sickness — 18; 16 Participants
Altitude Sickness
Primary: Acute Mountain Sickness — 19; 26 Participants
Hypoxia
Primary: Acute Mountain Sickness (AMS-C) as Assessed by the Environmental Symptoms Questionnaire. — 0.36; 0.21 scores on a scale
Acute Mountain Sickness
Primary: Time (Minutes) to Complete 2 Miles on a Treadmill — 1544; 1540 seconds
Hypoxia
Primary: Primary Objective Endurance Exercise Performance — 22.4; 24.5; 24.0; 24.6 minutes
Hypoxia · Altitude Hypoxia · Altitude Sickness
Primary: Oxygenation of the Brain — 54.6; 54.3; 59.4; 55.4 percentage of oxygen saturation
Hypertension, Pulmonary · Altitude Sickness
Primary: Mean Pulmonary Artery Pressure — 16.8667; 15.6545; 16.3800; 16.6833 mm Hg
Hypoxia · Altitude · Heart Failure
Primary: Peak Exercise Oxygen Consumption — 33.9; 37.6; 38.0; 33.9 ml/Kg/min — p=0.01
Prophylaxis of Acute Mountain Sickness
Primary: Number of Participants With Acute Mountain Sickness as Measured by the Lake Louise Score — 21; 21 Participants
Type 2 Diabetes
Primary: Insulin Sensitivity — 1.7; 2.2 unitless
Hypoxemia · Hypobaric Hypoxemia
Primary: Return of Oxygen Saturation to Baseline (Sea Level) Values — 6; 8; 10; 4 participants — p=0.3
Affect
Primary: Change From Baseline Subscales of Mood Survey Scale at 3 Hours — 0.54; -1.27; -2.22 score on a scale
Anemia, Kidney Disease, Chronic
Primary: Mean Dose Required to Achieve Target Hemoglobin of 11-12 g/dL — 150.3; 194.7; 98.7; 66.6 micrograms (mcg)
Hypoxia, Altitude
Primary: Performance Time — 17.03; 18.08; 16.32 minutes — p=0.047
Amyotrophic Lateral Sclerosis (ALS) · Neuromuscular Diseases
Primary: Percent Change in Maximal Inspiratory Pressure (MIP) — 0.3; -3.1; -4.8; -5.0 percentage change in MIP from baseline
Diabetes Mellitus
Primary: Number of Successful Glucose Readings — 449 Number of Glucose readings in range
Ozone Exposure During Rest and Exercise
Primary: Time-to-exhaustion on Maximal Cycling Bout — 209; 235 seconds — p=0.092
Airway Inflammation
Primary: Change From Baseline to 4 Hours in Sputum Percent Neutrophils — -0.04; -0.5 percent neutrophils — p=> 0.99
Migraine
Primary: Change in Pain Scores From 0-30 Minutes on a Visual Analog Scale (VAS) — 1.38; 1.22 units on a scale — p=0.674
High Altitude Headache
Primary: Change in Optic Nerve Sheath Diameter by Ultrasonography — 0.02; 0.02 mm — p=0.98
Sleep-disordered Breathing · Snoring
Primary: Pleural Pressure (Pes) — 9.3; 4.4 mmHg
Edema, Pulmonary · Immersion · Diving
Primary: Number of Participants With Pulmonary Edema — 7; 9 Participants — p=0.317
Hypoxia
Primary: Plasma Glucose Concentration — 93.8; 95.7; 94.1; 93.3 mg/dl
Glucose Metabolism · High Altitude
Primary: Rate of Exogenous Carbohydrate Oxidation — 0.44; 0.35 g/min